Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Esophageal Squamous Cell Carcinoma 8Esophageal Neoplasms 4Squamous Cell Carcinoma of Head and Neck 2Uterine Neoplasms 1Thyroid Neoplasms 1Thymoma 1Thymic epithelial tumor 1Pathologic Complete Response 1Ovarian Neoplasms 1Neoplasms 1Neoplasm Recurrence, Local 1Neoplasm Metastasis 1Mouth Neoplasms 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

Cisplatin 18Specimen Handling 10Radiotherapy 10Cetuximab 10Magnetic Resonance Spectroscopy 9Radiotherapy, Intensity-Modulated 8Carboplatin 71,2-diaminocyclohexaneplatinum II citrate 7pembrolizumab 6Platinum 6Paclitaxel 5Drug Therapy 5Celecoxib 5cemiplimab 4X-Rays 4Surgical Procedures, Operative 4Radiation 4Fluorouracil 4Biopsy 4Taxes 3Standard of Care 3Docetaxel 3durvalumab 2Radiotherapy, Image-Guided 2RRx-001 2Practice Guidelines as Topic 2Observation 2Nivolumab 2Injections 2Fenretinide 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Mouth Neoplasms × TP protocol × Clear all
NCT00933387 2016-05-04

A Study of Neoadjuvant Bio-C/T Followed by Concurrent Bio-R/T in High-risk Locally Advanced Oral Squamous Cell Carcinoma

National Health Research Institutes, Taiwan

Phase 2 Completed
47 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Mouth Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡